ロード中...
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
Pemetrexed (ALIMTA, LY231514, MTA) is a novel multitargeted antifolate that is currently approved for the treatment of metastatic nonsmall cell lung cancer (NSCLC). Recent evidence reveals that the drug’s efficacy is limited to nonsquamous lung cancer histology. As we further understand the drug’s m...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513199/ https://ncbi.nlm.nih.gov/pubmed/23226032 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|